Wemade Co., Ltd. Announces Pre-Registration for MIR 4, an Open World K-Fantasy MMORPG
29.7.2021 06:00:00 EEST | Business Wire | Press release
“From my battle to our war.” MIR 4, the unique open world K-Fantasy MMORPG, opens for global pre-registration on Thursday, 29 July.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210728006129/en/
Wemade 's MIR 4, the unique open world K-Fantasy MMORPG, opens for global pre-registration on Thursday, 29 July. Pre-registration will be available on MIR 4’s official website, the Google Play Store and the Apple App Store. Pre-registered users will enjoy various in-game items on launch. The game beautifully portrays the mystical and elegant life of the Orient, offering a truly singular experience for MMORPG players across the world. The global version is upgraded from the Korean in that it has adopted blockchain technology. The digital assets in MIR 4 can be made NFT or FT in order to buy, sell or trade for profit. The global release will be available in more than 170 countries on both mobile and PC. (Graphic: Business Wire)
The game beautifully portrays the mystical and elegant life of the Orient, offering a truly singular experience for MMORPG players across the world.
The game is designed to offer players the chance to choose their own paths without limitation. This might involve becoming a merchant, trading and selling materials to gain wealth, creating the most powerful clan in the world rising in power or simply venturing into the unknown with friends to tell a grand tale – the choice is entirely up to the player.
With no set guidelines defining success in the game, players instead focus on four fundamental principles: social, economic, political and competitive, to focus on their characters’ needs and wants, thus creating a cycle of life in the game’s world.
MIR 4 was first released in South Korea in November 2020. On release, it quickly became the country’s most downloaded game. The global version is upgraded from the Korean in that it has adopted blockchain technology. The digital assets in MIR 4 can be made NFT or FT in order to buy, sell or trade for profit.
Pre-registration will be available on MIR 4’s official website, the Google Play Store and the Apple App Store. Pre-registered users will enjoy various in-game items on launch.
The global release will be available in more than 170 countries in 12 languages (Korean, English, Japanese, Chinese/Traditional, Chinese/Simplified, Thai, Indonesian, Vietnamese, German, Spanish, Portuguese and Russian) on both mobile and PC. MIR 4’s global CBT will be held for four days, between 5 and 8 August 2021.
Visit www.mir4global.com for more details on this highly anticipated MMORPG.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210728006129/en/
Contact information
Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee,
PR Manager
+82-2-3709-2553
yeonghyun@wemade.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Collaborates with Chainguard to Strengthen Software Supply Chain Security through BlueVerse™ RightLogic6.8.2026 14:30:00 EEST | Press release
LTM, the Business Creativity partner to the world's largest enterprises, today announced a strategic collaboration with Chainguard, the trusted source for open source, to strengthen software supply chain security through BlueVerse™ RightLogic, LTM's cybersecurity assessment and risk assurance framework. The collaboration enables organizations to strengthen security while maintaining the speed and agility required for AI-enabled software development. With BlueVerse RightLogic, LTM combines AI-powered cyber risk assessment with a growing ecosystem of technology partners to help enterprises identify, assess, and remediate cyber exposure while accelerating AI adoption. Chainguard strengthens the BlueVerse RightLogic ecosystem by helping enterprises secure open-source components from the outset, complementing LTM's cybersecurity services to close the gap between AI-speed discovery and enterprise-speed remediation. As AI adoption accelerates, complex software supply chains and growing relian
teamLab Borderless in Tokyo Welcomes Over 4 Million Visitors from more than 185 Countries6.8.2026 14:07:00 EEST | Press release
teamLab Borderless: MORI Building DIGITAL ART MUSEUM (teamLab Borderless) in Tokyo has welcomed over 4 Million visitors as of July 31, 2026, approximately 2 years and 5 months since its opening.*1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806672709/en/ teamLab Borderless: MORI Building DIGITAL ART MUSEUM in Tokyo Welcomes Over 4 Million Visitors from more than 185 Countries These visitors arrived from more than 185 countries and regions. International visitors account for approximately 70% of the total number. Many of these international visitors travel from distant countries and regions, including the United States, Australia, Canada, the United Kingdom and Germany. Among those who visited Japan between February 2024 and June 2026, approximately 1 in every 12 travelers from the United States, and 1 in every 9 travelers from Australia visited teamLab Borderless.*2 teamLab Borderless was selected by the U.S. based int
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 20266.8.2026 14:00:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside chat at 8:00am ET. Management will also participate in the Stifel Biotech Summit in Newport, Rhode Island, on August 10, 2026. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under eva
Purina Named as First Publicly Announced NIQ ConnectAI Charter Client6.8.2026 13:45:00 EEST | Press release
NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today named Purina as the first publicly announced client in its ConnectAI Charter Program. The announcement follows NIQ’s launch of the program with five global organizations across personal care, pet care, beauty and beverages, with additional client announcements and case studies expected as engagements advance. Through ConnectAI, NIQ forward-deployed engineers and data scientists are working within Purina’s technology environment to explore how NIQ consumer and market intelligence can support everyday AI-enabled workstreams and help teams access relevant insights more efficiently. "Understanding the needs of pet owners requires a clear view of how consumer behaviors, shopping habits, and category trends are evolving,” said Brian Donovan, Strategy and Insights, Purina. “Purina is working with NIQ to explore how its trusted intelligence can be incorporated into Purina’s everyday, AI-enabled workstreams, helping our team
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin6.8.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-traumatic stress disorder (PTSD). The trial, titled "Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression," or PIVOT, reflects VA’s commitment to pursuing innovative solutions for veterans who have not responded to existing treatments. Compass will donate the study drug - COMP360, a synthetic, proprietary pharmaceutical-grade formulation of psilocybin optimized for stability and purity. Compass will support the education and training of the investigators and their training team through the provision of training
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom